GO:0003906 DNA-(apurinic or apyrimidinic site) endonuclease activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003906 describes the enzymatic cleavage of the C-O-P bond at apurinic/apyrimidinic (AP) sites in DNA, a central step in base excision repair (BER).
• AP endonucleases such as APE1 (human) and ExoIII (bacterial) create a single-strand break with a 3'-OH and 5'-deoxyribose phosphate, enabling downstream repair.
• The term includes enzymes from diverse organisms, including human APE1, bacterial TatD, and Drosophila ribosomal protein PO.
• Defects in AP endonuclease activity are linked to cancer, neurodegeneration, and altered drug responses.
• CRISPR knockout, knock-in, and point-mutation models are essential to dissect the causal roles of AP endonuclease genes in disease.
• Advanced methods such as DNA nanoprisms and proximity labeling enable sensitive detection of AP endonuclease activity in live cells and complex systems.
Description
DNA-(apurinic or apyrimidinic site) endonuclease activity, encoded by the Gene Ontology term GO:0003906, is a molecular function that catalyzes the cleavage of the C-O-P bond at AP sites generated when DNA glycosylases remove damaged bases. This activity is a critical step in the base excision repair (BER) pathway, which maintains genomic integrity by repairing oxidized, alkylated, or deaminated bases. Without efficient AP endonuclease activity, AP sites persist and can block DNA replication and transcription, leading to mutations and cell death. Researchers study this term to understand DNA repair mechanisms, to develop inhibitors or activators for therapeutic purposes, and to interpret disease-associated variants. The activity is conserved across evolution, from bacteria to humans, and is found in both dedicated repair enzymes and moonlighting proteins.
DNA-(apurinic or apyrimidinic site) endonuclease activity At A Glance
| GO ID | GO:0003906 |
|---|---|
| GO term | DNA-(apurinic or apyrimidinic site) endonuclease activity |
| Ontology | molecular_function |
| Synonym | abasic deoxyendoribonuclease activity; AP deoxyendoribonuclease activity; apurinic/apyrimidinic endodeoxyribonuclease activity; apurinic deoxyendoribonuclease activity; apyrimidinic deoxyendoribonuclease activity; deoxyribonuclease (apurinic or apyrimidinic) activity; endonuclease VIII activity; UV endonuclease |
| Major function | Cleavage of the C-O-P bond at AP sites in DNA during base excision repair |
| Pathway | Base excision repair (BER) |
| Substrates | DNA containing apurinic/apyrimidinic sites |
| Products | DNA with a single-strand break containing 3'-OH and 5'-deoxyribose phosphate |
| Cofactors | Mg2+ or other divalent metal ions (for many AP endonucleases) |
| Localization | Nucleus, mitochondria (for some isoforms) |
What Is GO:0003906?
GO:0003906 is defined as the catalysis of the cleavage of the C-O-P bond in the AP site created when DNA glycosylase removes a damaged base, involved in the DNA base excision repair pathway (BER). In simpler terms, it is the enzymatic activity that cuts DNA at a baseless site, preparing it for repair.
Why Is DNA-(apurinic or apyrimidinic site) endonuclease activity Important in Cell Biology?
AP endonuclease activity is essential for genome stability because unrepaired AP sites are cytotoxic and mutagenic. This activity is the rate-limiting step in BER, and its dysregulation is associated with cancer, neurodegenerative diseases, and aging. Moreover, AP endonucleases are targets for chemotherapeutic sensitization, as inhibiting their activity can enhance the efficacy of DNA-damaging agents.
• Maintains genomic integrity by repairing AP sites generated by DNA glycosylases.
• Prevents mutations and cell death caused by persistent AP sites.
• Plays a role in cancer development and progression; APE1 is overexpressed in many cancers.
• Involved in neurodegeneration; altered AP endonuclease activity is linked to neuronal loss.
• Serves as a therapeutic target for enhancing chemotherapy and radiotherapy.
• Enables DNA repair in mitochondria, affecting mitochondrial genome stability.
• Moonlighting functions in RNA metabolism and ribosomal proteins expand its biological roles.
• Essential for bacterial survival and pathogenesis, making it an antibiotic target.
• Used as a biomarker for oxidative stress and DNA damage.
• Facilitates CRISPR-based disease modeling by providing mechanistic insights.
What Happens During DNA-(apurinic or apyrimidinic site) endonuclease activity?
Recognition of AP Sites
In simple terms: The enzyme finds the missing base in DNA.
AP endonucleases scan DNA for AP sites, which are generated spontaneously or by DNA glycosylases. The enzyme flips the abasic site into its active site pocket, a process that involves conformational changes in both DNA and protein. This recognition is highly specific and ensures that only damaged sites are cleaved.
Catalytic Cleavage
In simple terms: The enzyme cuts the DNA backbone at the AP site.
Once bound, the enzyme catalyzes the hydrolysis of the C-O-P bond, creating a nick with a 3'-hydroxyl and a 5'-deoxyribose phosphate (dRP) residue. This cleavage is metal-dependent for many AP endonucleases, such as APE1, which uses Mg2+ to stabilize the transition state. The reaction is essential for generating a primer for DNA polymerase during BER.
Processing of the 5'-dRP Moiety
In simple terms: The leftover sugar phosphate is removed.
After cleavage, the 5'-dRP group must be removed to allow DNA polymerase to fill the gap. In humans, APE1 itself possesses a 3'-phosphodiesterase activity that can remove the dRP, or the dRP is removed by DNA polymerase beta lyase activity. This step is critical for completing repair.
Coordination with Other BER Factors
In simple terms: The enzyme works with a team of repair proteins.
AP endonucleases interact with other BER proteins, such as DNA polymerase beta, XRCC1, and ligase III, to coordinate repair. These interactions ensure efficient handoff of the repair intermediate and prevent accumulation of toxic breaks. The activity is also regulated by post-translational modifications and protein-protein interactions.
Key Genes Involved in GO:0003906 DNA-(apurinic or apyrimidinic site) endonuclease activity
The following genes encode proteins with demonstrated AP endonuclease activity or are directly involved in the BER pathway step catalyzed by GO:0003906.
| Gene | Major Role | Research Relevance |
|---|---|---|
| APEX1 | Major human AP endonuclease; cleaves AP sites and processes 3' termini | Overexpressed in cancers; target for inhibitor development |
| APEX2 | Mitochondrial AP endonuclease; maintains mitochondrial DNA | Linked to mitochondrial diseases and aging |
| TATDN1 | Human TatD-like protein with AP endonuclease activity | Emerging role in DNA repair and RNA metabolism |
| TATDN2 | Human TatD-like protein; AP endonuclease activity | Potential tumor suppressor or oncogene |
| TATDN3 | Human TatD-like protein; AP endonuclease activity | Implicated in immune regulation |
| EXOIII | Bacterial AP endonuclease (E. coli) | Model enzyme for studying AP endonuclease mechanism |
| RPLP0 | Drosophila ribosomal protein PO with AP endonuclease activity | Moonlighting function in DNA repair |
| OGG1 | DNA glycosylase that generates AP sites for AP endonucleases | Defective in some cancers; interacts with APE1 |
| UNG | Uracil-DNA glycosylase; generates AP sites | Target for antiviral and anticancer therapy |
| MUTYH | Adenine DNA glycosylase; generates AP sites | Mutations cause colorectal cancer |
| NEIL1 | Nei-like DNA glycosylase; generates AP sites | Involved in oxidative DNA damage repair |
| NEIL2 | Nei-like DNA glycosylase; generates AP sites | Roles in transcription-coupled repair |
| NTHL1 | Endonuclease III-like glycosylase; generates AP sites | Biallelic mutations cause cancer predisposition |
| XRCC1 | Scaffold protein in BER; interacts with AP endonucleases | Polymorphisms affect DNA repair capacity |
| POLB | DNA polymerase beta; fills gaps after AP endonuclease cleavage | Target for chemosensitization |
| LIG3 | DNA ligase III; seals nicks after BER | Essential for mitochondrial BER |
| FEN1 | Flap endonuclease; processes BER intermediates | Defects cause genome instability |
How Is DNA-(apurinic or apyrimidinic site) endonuclease activity Regulated?
AP endonuclease activity is regulated at multiple levels. APE1 expression is induced by oxidative stress through transcription factors such as NRF2 and AP-1. Post-translational modifications, including acetylation, phosphorylation, and ubiquitination, modulate APE1 activity and stability. Additionally, protein-protein interactions with XRCC1 and other BER factors coordinate the repair process. In bacteria, TatD enzymes are regulated by growth phase and stress conditions.
DNA-(apurinic or apyrimidinic site) endonuclease activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| APEX1 | Cancer (lung, breast, prostate); chemoresistance | Knockout and overexpression in cancer cell lines; xenograft models |
| APEX2 | Mitochondrial dysfunction; neurodegeneration | Mitochondria-targeted knockout in neurons |
| TATDN1 | Cancer; RNA metabolism disorders | CRISPR knockout in HeLa cells; RNA-seq |
| RPLP0 | Ribosomopathy; DNA repair deficiency | Drosophila knockout; AP endonuclease assays |
| MUTYH | Colorectal cancer; oxidative DNA damage | Knock-in mouse models; organoids |
Cancer
AP endonuclease activity is often upregulated in cancer cells, contributing to resistance to DNA-damaging therapies. APE1 overexpression is observed in multiple cancers, including lung, breast, and prostate cancer, and is associated with poor prognosis. Inhibiting APE1 sensitizes cancer cells to chemotherapy and radiotherapy. Furthermore, APE1 variants with altered endoribonuclease activity have been identified in human populations, potentially affecting cancer susceptibility.
Neurodegeneration
Deficient AP endonuclease activity leads to accumulation of AP sites and oxidative DNA damage in neurons, contributing to neurodegenerative diseases such as Alzheimer's and Parkinson's disease. APE1 dysfunction has been linked to neuronal loss and cognitive decline in animal models.
Infectious Diseases
Bacterial AP endonucleases, such as TatD and ExoIII, are essential for survival under oxidative stress and for pathogenesis. Targeting these enzymes could lead to new antibiotics.
From DNA-(apurinic or apyrimidinic site) endonuclease activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does APEX1 knockout affect cell survival after oxidative stress? | CRISPR knockout in HEK293T or HeLa cells |
| What is the effect of a cancer-associated APEX1 point mutation on AP endonuclease activity? | Point mutation knock-in via CRISPR in isogenic cell lines |
| Can APE1 be tagged for live-cell imaging? | Knock-in of fluorescent tag (e.g., GFP) at the APEX1 locus |
| Does overexpression of APEX1 confer chemoresistance? | Doxycycline-inducible overexpression in cancer cell lines |
| What are the interactors of AP endonucleases in complex systems? | Proximity labeling (e.g., APEX2) with mass spectrometry |
| Can AP endonuclease activity be measured in live cells? | DNA nanoprism-based fluorescent probes |
How to Study the DNA-(apurinic or apyrimidinic site) endonuclease activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Oligonucleotide cleavage assay | AP endonuclease activity in vitro | Enzyme kinetics and inhibitor screening |
| DNA nanoprism imaging | Real-time AP endonuclease activity in live cells | Subcellular localization and dynamics |
| Proximity labeling (APEX2) | Protein-protein interactions of AP endonucleases | Interactome mapping in complex systems |
| CRISPR knockout screen | Genes affecting sensitivity to AP endonuclease inhibition | Target discovery and synthetic lethality |
| RNA-seq | Transcriptional changes upon AP endonuclease perturbation | Pathway analysis and biomarker discovery |
| Western blot | Protein expression levels of AP endonucleases | Validation of knockout or overexpression |
| Comet assay | DNA single-strand breaks (including AP sites) | Genotoxicity assessment |
| Mass spectrometry | Post-translational modifications of AP endonucleases | Regulation studies |
Enzymatic Activity Assays
AP endonuclease activity is typically measured using oligonucleotide substrates containing a tetrahydrofuran (THF) AP site analog. Cleavage products are resolved by gel electrophoresis or detected by fluorescence. These assays are used to quantify specific activity and to screen inhibitors.
Live-Cell Imaging
DNA nanoprisms functionalized with fluorophores and AP site mimics enable real-time imaging of AP endonuclease activity in live cells. This method provides spatial and temporal resolution of repair events.
Proximity Labeling Proteomics
Engineered APEX2 or TatD enzymes fused to bait proteins can biotinylate nearby proteins, allowing identification of AP endonuclease interactors in challenging biological systems. This approach reveals novel components of the BER complex.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout libraries can be used to identify genes that modulate sensitivity to AP endonuclease inhibitors or DNA-damaging agents. Such screens uncover synthetic lethal interactions and resistance mechanisms.
How CRISPR Can Be Used to Study GO:0003906 DNA-(apurinic or apyrimidinic site) endonuclease activity
Knockout
CRISPR knockout of APEX1 or other AP endonuclease genes in cell lines such as HEK293T or HeLa results in accumulation of AP sites and increased sensitivity to oxidative stress. These models are used to study the essentiality of the enzyme and to identify compensatory pathways.
Point Mutation
Point mutations identified in human populations, such as those in APEX1, can be introduced via CRISPR base editing or homology-directed repair to assess their impact on AP endonuclease activity and cellular phenotypes. Such models help determine whether variants are pathogenic.
Knock-in
Knock-in of epitope tags (e.g., FLAG, GFP) at the endogenous APEX1 locus allows for live-cell imaging and proteomic analysis of the enzyme under native regulation. This approach preserves physiological expression levels.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of APEX1 can model the upregulation observed in cancers and test its role in chemoresistance. Overexpression models are useful for drug screening.
How EDITGENE Supports DNA-(apurinic or apyrimidinic site) endonuclease activity Research
Researchers studying DNA-(apurinic or apyrimidinic site) endonuclease activity-related genes often need to determine whether a candidate gene is causally involved in DNA repair, disease progression, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for DNA-(apurinic or apyrimidinic site) endonuclease activity research.
Frequently Asked Questions About DNA-(apurinic or apyrimidinic site) endonuclease activity
What is DNA-(apurinic or apyrimidinic site) endonuclease activity?
It is the enzymatic activity that cleaves the DNA backbone at apurinic/apyrimidinic (AP) sites, a key step in base excision repair.
What genes are involved in DNA-(apurinic or apyrimidinic site) endonuclease activity?
Major genes include APEX1, APEX2, TATDN1, TATDN2, TATDN3, and in Drosophila, RPLP0.
What is the GO ID for AP endonuclease activity?
The Gene Ontology ID is GO:0003906.
How is AP endonuclease activity measured?
Common methods include oligonucleotide cleavage assays, live-cell imaging with DNA nanoprisms, and proximity labeling proteomics.
What diseases are associated with AP endonuclease dysfunction?
Cancer, neurodegeneration, and infectious diseases are linked to altered AP endonuclease activity.
What is the role of APE1 in cancer?
APE1 is often overexpressed in cancers and contributes to resistance to DNA-damaging therapies.
Can CRISPR be used to study AP endonuclease genes?
Yes, CRISPR knockout, knock-in, and point mutation models are widely used to dissect gene function.
What are the substrates of AP endonucleases?
The substrates are DNA molecules containing apurinic/apyrimidinic sites.
What are the products of AP endonuclease cleavage?
The products are DNA with a single-strand break containing a 3'-OH and a 5'-deoxyribose phosphate.
How does AP endonuclease activity relate to base excision repair?
It is the second step in BER, following glycosylase removal of damaged bases.
Conclusion
DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906) is a fundamental molecular function in DNA repair, with critical roles in genome stability and disease. Understanding its mechanism, regulation, and genetic players is essential for developing targeted therapies. EDITGENE offers comprehensive CRISPR services to facilitate this research, from gene knockout to high-throughput screening.
References
- 1. Dorival J et al.. 2023. Human and bacterial TatD enzymes exhibit apurinic/apyrimidinic (AP) endonuclease activity.. Nucleic Acids Res 51(6):2838-2849 PMID: 36881763
- 2. Li JJ et al.. 2023. Protein-Scaffolded DNA Nanostructures for Imaging of Apurinic/Apyrimidinic Endonuclease 1 Activity in Live Cells.. Anal Chem 95(7):3551-3555 PMID: 36774652
- 3. Liang M et al.. 2022. Apurinic/apyrimidinic endonuclease triggered doxorubicin-releasing DNA nanoprism for target therapy.. Cell Cycle 21(24):2627-2634 PMID: 35943146
- 4. Caradonna SJ et al.. 1982. DNA glycosylases.. Mol Cell Biochem 46(1):49-63 PMID: 6287206
- 5. Wilson DM 3rd et al.. 1995. Incision activity of human apurinic endonuclease (Ape) at abasic site analogs in DNA.. J Biol Chem 270(27):16002-7 PMID: 7608159
- 6. Sroka TJ et al.. 2025. An enzymatic cascade enables sensitive and specific proximity labeling proteomics in challenging biological systems.. Nat Commun 16(1):9691 PMID: 41184298
- 7. Kim WC et al.. 2014. Altered endoribonuclease activity of apurinic/apyrimidinic endonuclease 1 variants identified in the human population.. PLoS One 9(3):e90837 PMID: 24595156
- 8. Yacoub A et al.. 1996. Drosophila ribosomal protein PO contains apurinic/apyrimidinic endonuclease activity.. Nucleic Acids Res 24(21):4298-303 PMID: 8932386
